CooperVision · 19 hours ago
Global Financial Analyst
CooperVision is a global leader in contact lens innovation and vision care solutions. As a Global Financial Analyst, you will support financial planning and analysis, budgeting, and forecasting for Global Information Services and Finance leadership teams, driving strategic decisions across the company.
Responsibilities
Prepare accurate financial reports for capital projects and operating expenses (Opex)
Manage capital expenditure approvals and ensure compliance with company policies
Collaborate with accounting teams on journal entries, project reviews, and lease reporting
Maintain and update budgeting and forecasting models and headcount planning tools
Provide variance analysis and actionable recommendations to senior leadership
Support global and regional teams in budget preparation and forecasting submissions
Monitor professional services, software licensing, and maintenance expenses
Plus other duties as assigned
Qualification
Required
3+ years in FP&A, financial analysis, or corporate finance
Bachelor's degree in Finance, Accounting, or Business
Advanced Excel and strong proficiency in Microsoft Office
Excellent analytical, problem-solving, and communication skills
Ability to manage multiple priorities in a fast-paced environment
Preferred
Experience in IT budgeting
CPA/CMA/MBA
Benefits
Comprehensive health, vision, and retirement benefits.
Opportunities for professional development and career advancement.
Company
CooperVision
CooperVision is one of the world’s leading manufacturers of soft contact lenses and related products and services. It is a sub-organization of The Cooper Companies.
H1B Sponsorship
CooperVision has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (9)
2024 (12)
2023 (14)
2022 (7)
2021 (13)
2020 (11)
Funding
Current Stage
Late StageRecent News
2026-01-06
FierceBiotech
2025-09-28
Company data provided by crunchbase